No Data
No Data
No Data
No Data
No Data
FibroBiologics Files to Sell 1.8M Units
Seeking AlphaApr 27 03:23
FibroBiologics, Charles River Laboratories Sign Letter Of Intent Allowing For Transfer, Testing And Validation Of Technology
This agreement comes ahead of entering into an anticipated master services agreement for the development and manufacture of FibroBiologics' master cell bank, working cell bank, and fibroblast-based sp
BenzingaApr 25 20:02
FibroBiologics Plans to Collaborate With Charles River to Manufacture Fibroblast-based Spheroids
HOUSTON, April 25, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc., (NASDAQ:FBLG) ("FibroBiologics") and Charles River Laboratories ("Charles River"), a highly respected, global provider of drug discovery,
GlobeNewswireApr 25 20:00
Ally Financial Reports Upbeat Earnings, Joins Badger Meter, Genuine Parts And Other Big Stocks Moving Higher On Thursday
U.S. stocks were lower, with the Nasdaq Composite falling over 50 points on Thursday.Shares of Ally Financial Inc. (NYSE:ALLY) rose sharply during Thursday's session after the company reported better-
BenzingaApr 19 01:58
FibroBiologics Granted Patent for Regeneration of Cartilage-Type Cells by the Australian Patent Office
HOUSTON, April 11, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (NASDAQ:FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued and pending with a focus on the development of
GlobeNewswireApr 11 21:31
FibroBiologics Presents Data From Dermal Fibroblast Spheroid-Based Treatment Of Chronic Wounds In A Diabetes Mouse Model At Advanced Wound Care Summit USA
FibroBiologics, Inc., (NASDAQ:FBLG) ("FibroBiologics"), a clinical-stage biotechnology company with 150+ patents issued and pending for the development of therapeutics and potential cures for chronic
BenzingaApr 4 21:32
No Data
No Data